【五养堂药业是哪个国家的品牌？】

外推网助力五养堂药业品牌出海！通过在本页面挂载五养堂药业品牌的产品链接和联系邮箱，可以提高五养堂药业产品曝光！跨境电商爆单神器，目前只要100元/年哦~

浙江五养堂药业有限公司使命是弘扬中医药五行养生文化，以现代生物科技制造灵芝、三叶青、铁皮石斛和红曲等道地药材的趁鲜口型中药饮片、保健食品、中药养生食品，以振兴中药保健食品产业和推动中药食疗食养、促进人类健康为己任，创新发展养肝（保肝明目）、养心（安心养神）、养脾（健脾益胃）、养肺（润肺养颜）、养肾（补肾益精）的五养系列健康产品，打造具有民族特色的中药保健养生和健康服务品牌。

浙江五养堂药业有限公司成立于2004年1月，其前身是浙江益圣菌物发展有限公司，由浙江省林业科学研究院、丽水市食用菌研究开发中心和吴学谦教授等40名自然人共同发起组建。2013年经严格的评估和公开挂牌交易，浙江省林业科学研究院的股份由吴学良等股东受让持有，国有股份全部退出，正式更名为“浙江五养堂药业有限公司”。

公司厂区占地面积20亩，建筑面积16000多平方米，建有中药饮片GMP车间、保健食品GMP车间、生物发酵车间、趁鲜冷冻超微破壁车间等四大健康产品生产线，目前是浙江省较大的灵芝破壁孢子粉、真菌多糖提取加工和三叶青口服型中药饮片趁鲜冷冻加工基地，产品远销欧美、日本、香港、台湾等国家和地区。

五养堂选育成功了“浙青1号“等新品种、掌握了三叶青的核心种植技术，已经申请了“一种果林地仿生套种袋式三叶青方法”等8项专利，通过三叶青趁鲜口服型加工技术改造和研发三叶青保健食品与抗菌抗炎退烧药品，拟从一产（规范种植）+二产（药品、保健食品加工）+三产（线上线下营销服务、健康服务、健康管理、健康保险、供应链管理）全产业链运作，将这一“天然的植物抗生素”三叶青产业做强做大。

五养堂将于2016年在新三板系统挂牌，并争取在1-2年内进入创新层，通过联合上市大企业搞定向增发，借助资本市场的力量将五养堂健康产业做强做大，实现百亿规模的企业梦想，并力求将五行中医药养生文化结合中国特色健康产品走向全世界。

英文翻译：The mission of Zhejiang wuyangtang Pharmaceutical Co., Ltd. is to carry forward the five elements health preservation culture of traditional Chinese medicine, to produce fresh Chinese herbal pieces, health food and health food of traditional Chinese medicine, such as Ganoderma lucidum, Trifolium, Dendrobium candidum and Monascus, with modern biotechnology, to revitalize the industry of health food of traditional Chinese medicine, promote the diet and nutrition of traditional Chinese medicine, and promote human health as its own duty, and innovate and develop the liver (liver protection Five series of health products, i.e. Mingmu, Yangxin (peace of mind and mind), yangpi (invigorating the spleen and stomach), Yangfei (moistening the lungs and beautifying the face) and Yangshen (invigorating the kidney and benefiting the essence), will build a brand of traditional Chinese medicine health care and health service with national characteristics. Zhejiang wuyangtang Pharmaceutical Co., Ltd. was founded in January 2004. Its predecessor is Zhejiang Yisheng fungus development Co., Ltd. which was jointly initiated and established by 40 natural persons including Zhejiang Academy of Forestry Sciences, Lishui edible fungus research and development center and Professor Wu Xueqian. In 2013, after strict evaluation and public listing, the shares of Zhejiang Academy of Forestry Sciences were transferred and held by Wu Xueliang and other shareholders, and all state-owned shares were withdrawn, officially renamed as "Zhejiang wuyangtang Pharmaceutical Co., Ltd.". The factory area of the company covers an area of 20 mu, with a building area of more than 16000 square meters. It has four major production lines for healthy products, including GMP workshop for Chinese herbal pieces, GMP workshop for health food, biological fermentation workshop, ultra-fine wall breaking workshop for fresh freezing. At present, it is a large base for the extraction and processing of Ganoderma lucidum wall breaking spore powder, fungal polysaccharide and Sanyeqing oral Chinese herbal pieces while fresh freezing in Zhejiang Province. The products are sold far Europe, America, Japan, Hong Kong, Taiwan and other countries and regions. Wuyangtang has successfully selected new varieties such as "zheqing No.1" and mastered the core planting technology of sanyeqin. It has applied for eight patents such as "a bionic interplanting bag type of sanyeqin in fruit forest". Through the technological transformation of sanyeqin taking advantage of the fresh oral processing technology and the research and development of sanyeqin health food and anti-bacterial, anti-inflammatory and fever reducing drugs, it is planned to produce from the first (standard planting) + the second (medicine, health food) Product processing) + three industries (online and offline marketing services, health services, health management, health insurance, supply chain management) operate in the whole industrial chain, making this "natural plant antibiotic" three leaf green industry stronger and bigger. Wuyangtang will be listed in the new three board system in 2016, and strive to enter the innovation layer within 1-2 years. Through joint listing of large enterprises to conduct targeted additional issuance, with the help of capital market, wuyangtang health industry will be stronger and bigger, and realize the enterprise dream of 10 billion scale, and strive to integrate the five elements of traditional Chinese medicine health culture with Chinese characteristics of health products to the world.

本文链接： https://www.waitui.com/brand/b6e82ab79.html 联系电话：请联系客服添加